Sèverine Garnier
Impact in
-
- Cancer Genomics and Diagnostics
-
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 9
- Cancer Treatment and Pharmacology 2
- Cancer Cells and Metastasis 2
- HER2/EGFR in Cancer Research 2
- PARP inhibition in cancer therapy 2
-
- Cancer Genomics and Diagnostics 7
- Co-authors
- Daniel Birnbaum (14 shared papers)François Bertucci (14 shared papers)Max Chaffanet (13 shared papers)Arnaud Guillé (15 shared papers)Nadine Carbuccia (12 shared papers)Pascal Finetti (6 shared papers)Anthony Gonçalvès (11 shared papers)José Adélaı̈de (12 shared papers)
- Journals
- Malaria Journal (3 papers)JCO Precision Oncology (3 papers)Journal of Clinical Oncology (2 papers)Molecular Oncology (2 papers)Cancers (2 papers)
- Partner nations
- FranceCanadaUnited States
In The Last Decade
Sèverine Garnier
22 papers receiving 405 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 84
- Oncology 124
- Genetics 38
- Pulmonary and Respiratory Medicine 64
- Pathology and Forensic Medicine 33
Countries citing papers authored by Sèverine Garnier
This map shows the geographic impact of Sèverine Garnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sèverine Garnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sèverine Garnier more than expected).
Fields of papers citing papers by Sèverine Garnier
This network shows the impact of papers produced by Sèverine Garnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sèverine Garnier. The network helps show where Sèverine Garnier may publish in the future.
Co-authors
The 25 scholars most cited alongside Sèverine Garnier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 66 | |
| 2 | Human opiorphin is a naturally occurring antidepressant acting selectively on enkephalin-dependent delta-opioid pathways. | 2010 | 52 |
| 3 | 2022 | 48 | |
| 4 | 2019 | 39 | |
| 5 | 2019 | 27 | |
| 6 | 2019 | 25 | |
| 7 | 2017 | 23 | |
| 8 | 2012 | 23 | |
| 9 | 2014 | 17 | |
| 10 | 2019 | 14 | |
| 11 | 2012 | 14 | |
| 12 | 2022 | 13 | |
| 13 | 2024 | 9 | |
| 14 | 2022 | 7 | |
| 15 | 2019 | 7 | |
| 16 | 2022 | 6 | |
| 17 | 2020 | 6 | |
| 18 | 2019 | 5 | |
| 19 | 2018 | 4 | |
| 20 | 2018 | 3 |
About Sèverine Garnier
Sèverine Garnier is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine, having authored 22 papers that have together received 411 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (3 papers), Renal cell carcinoma treatment (2 papers), Cancer Treatment and Pharmacology (2 papers), Malaria Research and Control (2 papers), Cancer Cells and Metastasis (2 papers), HER2/EGFR in Cancer Research (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Cancer Research (84 citations), Oncology (124 citations), Genetics (38 citations), Pulmonary and Respiratory Medicine (64 citations) and Pathology and Forensic Medicine (33 citations). Sèverine Garnier has collaborated with scholars based in France, Canada and United States. Frequent co-authors include Daniel Birnbaum, François Bertucci, Max Chaffanet, Arnaud Guillé, Nadine Carbuccia, Pascal Finetti, Anthony Gonçalvès, José Adélaı̈de, C. Rougeot and Hervé Javelot. Their work appears in journals such as Malaria Journal, JCO Precision Oncology, Journal of Clinical Oncology, Molecular Oncology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.